Clinical Trial Update: Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

View source ↗

Summary

This clinical trial update reports on signatures of response and resistance to mosunetuzumab in follicular lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Lunsumio (mosunetuzumab) (mosunetuzumab)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Follicular Lymphoma | Status: COMPLETED